Glucose Biosensors Market Size, Share, By Type (Continuous Glucose Monitoring, and Self-monitoring Blood Glucose), By Technology (Electrochemical Biosensors, Optical Biosensors, and Others), By End User (Hospitals, Homecare, and Diagnostic Center), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI566524 | Publish Date: October 2024 | No. of Pages: 190

Glucose Biosensors Market Companies

  • Abbott
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • PalmSens
  • Biolinq Incorporated
  • Medtronic Pvt. Ltd.
  • Ascensia Diabetes Care Holdings AG
  • Nova Diabetes Care
  • Sanofi
  • Trividia Health Inc.
  • Bayer
  • LifeScan IP Holdings, LLC.
  • Nutrix AG.

 

Recent News:

  • DexCom, Inc., the global leader in real-time continuous glucose monitoring for people with diabetes, announced that Stelo, the first over-the-counter glucose biosensor in the U.S., is now available for purchase without a prescription at Stelo.com in August 2024.
  • Researchers at Nano Life Science Institute, Kanazawa University report in Biosensors and Bioelectronics: X a novel approach for detecting a particular biomolecule associated with several diseases in June 2024. The results show good sensitivity and selectivity, and may lead to the development of a low-cost, rapid detection device useful in cancer prognosis.
  • Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition in September 2019. The two companies will take an innovative approach to connected care by developing tools that combine the revolutionary FreeStyle Libre technology with insulin dosing information for future smart pens, insulin titration apps and cloud software.